Ailanthone Inhibits Non-Small Cell Lung Cancer Cell Growth Through Repressing DNA Replication Via Downregulating RPA1

Total Page:16

File Type:pdf, Size:1020Kb

Ailanthone Inhibits Non-Small Cell Lung Cancer Cell Growth Through Repressing DNA Replication Via Downregulating RPA1 FULL PAPER British Journal of Cancer (2017) 117, 1621–1630 | doi: 10.1038/bjc.2017.319 Keywords: ailanthone; non-small cell lung cancer; DNA replication; RPA1; Chinese medicine Ailanthone inhibits non-small cell lung cancer cell growth through repressing DNA replication via downregulating RPA1 Zhongya Ni1, Chao Yao1, Xiaowen Zhu1, Chenyuan Gong1, Zihang Xu2, Lixin Wang3, Suyun Li4, Chunpu Zou2 and Shiguo Zhu*,1,3 1Laboratory of Integrative Medicine, School of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, 1200 Cai Lun Rd, Shanghai 201203, PR China; 2Department of Internal Classic of Medicine, School of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, 1200 Cai Lun Rd, Shanghai 201203, PR China; 3Department of Immunology and Pathogenic Biology, School of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, 1200 Cai Lun Rd, Shanghai 201203, PR China and 4Department of Pathology, School of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, 1200 Cai Lun Rd, Shanghai 201203, PR China Background: The identification of bioactive compounds from Chinese medicine plays a crucial role in the development of novel reagents against non-small cell lung cancer (NSCLC). Methods: High throughput screening assay and analyses of cell growth, cell cycle, apoptosis, cDNA microarray, BrdU incorporation and gene expression were performed. Results: Ailanthone (Aila) suppressed NSCLC cell growth and colony formation in vitro and inhibited NSCLC tumour growth in subcutaneously xenografted and orthotopic lung tumour models, leading to prolonged survival of tumour-bearing mice. Moreover, Aila induced cell cycle arrest in a dose-independent manner but did not induce apoptosis in all NSCLC cells. Furthermore, 1222 genes were differentially expressed upon Aila administration, which were involved in 21 signal pathways, such as DNA replication. In addition, Aila dose-dependently decreased BrdU incorporation and downregulated the expression of replication protein A1 (RPA1). Conclusions: Aila inhibited the growth of NSCLC cells through the repression of DNA replication via downregulating RPA1, rather than through cell cycle arrest and apoptosis. Our findings suggested that Aila could be used as a promising therapeutic candidate for NSCLC patients. Lung cancer is the leading cause of cancer death worldwide and 5-year survival rate is still less than 5%. Therefore, it is emergently non-small cell lung cancer (NSCLC) is the most common type and necessary to develop novel treatment strategies to improve represents 80% of all lung cancers. In China, approximately efficiency and reduce mortality of lung cancer. 4 292 000 new cancer cases and 2 814 000 cancer deaths occurred in Natural products are a major resource for the development of 2015, and lung cancer is also the most common cancer and the novel drug leads (Cragg and Newman, 2013). Chinese medicine leading cause of cancer death (Chen et al, 2015). Although the has been extensively documented over the centuries, which has a 5-year survival rate has been improved owing to the advances in long history of use in cancer treatment, showing significantly the management of NSCLC over the past 30 years, the overall improved therapeutic efficacy, reduced side effects of *Correspondence: Dr S Zhu; E-mail: [email protected] Received 8 June 2017; revised 10 August 2017; accepted 18 August 2017; published online 12 October 2017 r 2017 Cancer Research UK. All rights reserved 0007 – 0920/17 www.bjcancer.com | DOI:10.1038/bjc.2017.319 1621 BRITISH JOURNAL OF CANCER Ailanthone inhibits NSCLC cell growth chemotherapy and prolonged survival (He et al, 2016a; Zheng et al, six-well plates at a density of 200 cells per well. Aila was added to 2017). Therefore, the identification of bioactive compounds from the cells at different final concentrations (0, 0.078 and 0.156 mM), Chinese medicine plays a crucial role in the development of new and then the cells were incubated for 12 days. The colonies were anticancer reagents. fixed by 4% paraformaldehyde for 15 min, stained with crystal In the present study, high throughput screening assay showed violet for 15 min and then imaged and counted under a phase- that ailanthone (Aila) possessed the potential to inhibit NSCLC cell contrast microscope. growth. Aila is a main active compound of the stem barks of Ailanthus altissima, which is traditionally used to treat ascariasis, Subcutaneous xenograft tumour models. All animal procedures, diarrhoea, spermatorrhoea, bleeding and gastrointestinal diseases, including tumour transplantation, tumour volume monitoring and and it has been recently found to have anti-inflammatory and anti- killing, were approved by the Institutional Animal Care and Use tumour activities (Kim et al, 2015; Wang et al, 2016). Analyses of Committee at Shanghai University of Traditional Chinese cell growth, cell cycle, apoptosis, cDNA microarray, BrdU Medicine. For subcutaneous xenograft model, male Balb/c nude incorporation and gene expression revealed that Aila could mice (6–8-week-old, weighing 18–20 g) were purchased from significantly inhibit NSCLC cell growth both in vitro and in vivo. Shanghai SLAC Laboratory Animal Co., Ltd (Shanghai, China) and 6 Moreover, Aila repressed DNA replication in a dose-dependent maintained under an SPF environmental condition. Briefly, 3  10 manner and significantly downregulated replication protein A1 of H1975 cells or A549 cells were subcutaneously inoculated in the (RPA1). This finding indicated that Aila inhibited NSCLC cell back of nude mice. When tumour volume reached approximately 3 growth through targeting replication stress, suggesting that Aila 100 mm , mice were randomly assigned and administered with could be used as a promising therapeutic candidate in NSCLC different doses of Aila via intraperitoneal (IP) injection. The treatment. tumour volume and body weight were determined every 3 days. Tumour volume was calculated using the following formula: V ¼ (p/8)a  b2, where V ¼ tumour volume, a ¼ maximum tumour MATERIALS AND METHODS diameter and b ¼ minimum tumour diameter. Mice were huma- nely killed by CO2 suffocation when the tumour volume reached 3 Reagents. Aila was purchased from BioBioPha Co., Ltd (Yunnan, 2000 mm . China). Cell cycle kit was obtained from Biotime (Beijing, China). Biochemistry and histology. To evaluate the safety of Aila, mice Annexin V-FITC apoptosis kit and bromodeoxyuridine (BrdU) in the subcutaneous xenograft model were killed on day 58, and flow cytometry kit were supplied from BD Biosciences (San Jose, serum, liver and kidney were collected. Serum levels of alanine CA, USA). RNA extraction kit, PrimeScript RT MasterMix kit and aminotransferase (ALT), aspartate aminotransferase (AST), albu- SYBR Premix Ex Taq kit were provided by Takara (Dalian, China). min (ALB) and creatinine (CREA) were determined. Liver and Antibodies against caspase-3, PARP (poly ADP-ribose polymerase) kidney were fixed with 10% fresh formalin, embedded in paraffin, and actin as well as secondary antibodies were purchased from Cell cut into 4-mm sections, stained with haematoxylin–eosin and then Signaling Technology (Danvers, MA, USA). Antibodies against observed under a light microscope (  100 and  400 RPA1 and proliferating cell nuclear antigen (PCNA) were obtained magnification). from Santa Cruz (CA, USA). Mouse anti-human g-H2AX monoclonal antibody and goat anti-mouse IgG Alexa Fluro 488 Orthotopic lung tumour models and bioluminescent imaging. were purchased from Abcam (Cambridge, MA, USA). ECL western Male SCID-Bg mice (6–8-week-old) were purchased from Vital blotting substrate kit was supplied from Merck Millipore (Billerica, River Laboratory Animal Technology Co. (Beijing, China) and MA, USA). Amaxa cell line nucleofector kit T was purchased from maintained under an SPF environmental condition. Mice were Lonza (Cologne, Germany). MTT assay kit, cisplatin (DDP) and anaesthetised with 0.5% mebubarbital, and the left chest was camptothecin (CPT) were provided by Sigma-Aldrich (St Louis, shaved and exposed. Briefly, 1  106 eGFP-FFLuc þ A549 cells in MO, USA). 50 ml serum-free DMEM medium were mixed with 50 ml matrigel, and then the mixture was injected into the left lung. On day 4 after Cell culture. Human NSCLC A549, H1299 and H1975 cell lines À g were obtained from Shanghai Cell Bank of Chinese Academy of injection, mice were treated with 2 mg kg of Aila via IP Sciences. A549 cells were cultured in high glucose DMEM (Gibco, administration every 3 days, and the tumour volume was weekly Life Technologies, Grand Island, NY, USA) supplemented with monitored by imaging isoflurane-anaesthetised mice using the 10% foetal bovine serum (FBS; Gibco) and 1% penicillin and IVIS system (Xenogen, Alameda, CA, USA). streptomycin in 5% CO2. H1299 and H1975 cells were cultured in Cell cycle analysis. A total of 3  105 of A549, H1299 and H1975 RPMI 1640 (Gibco) supplemented with 10% FBS and 1% penicillin cells were respectively seeded in 6-cm plates and incubated and streptomycin in 5% CO2. overnight. Cells were then incubated with different concentrations Cell viability assay. MTT assay was performed to determine the (0, 0.625, 1.25, 2.5 and 5.0 mM) of Aila for 24 h. Subsequently, cells effect of Aila on the viability of NSCLC cells. Briefly, A549, H1299 were harvested, washed with ice-cold PBS, then fixed with 70% and H1975 cells were respectively seeded in 96-well plates at a ethanol overnight at À 20 1C and stained with propidium iodide density of 4  103 cells per well. Aila or DDP was added to the cells (PI) at 37 1C for 30 min in the dark. The DNA content was at different final concentrations (0, 0.078, 0.156, 0.3125, 0.625, 1.25, determined using a FACS Calibur cytometer (BD Biosciences) and 2.5, 5.0, 10 and 20 mM). At 24, 48 and 72 h, MTT was added to the analysed by the FCS Express v2.0 software (De Novo Software, cells at a final concentration of 0.5 mg ml À 1.
Recommended publications
  • POLE2 Knockdown Reduce Tumorigenesis in Esophageal Squamous Cells Yongjun Zhu, Gang Chen, Yang Song, Zhiming Chen* and Xiaofeng Chen*
    Zhu et al. Cancer Cell Int (2020) 20:388 https://doi.org/10.1186/s12935-020-01477-4 Cancer Cell International PRIMARY RESEARCH Open Access POLE2 knockdown reduce tumorigenesis in esophageal squamous cells Yongjun Zhu, Gang Chen, Yang Song, Zhiming Chen* and Xiaofeng Chen* Abstract Background: Esophageal squamous cell carcinoma (ESCC) is one of the most frequent malignant tumors originated from digestive system around the world and the treatment was limited by the unclear mechanism. DNA polymerase epsilon 2, accessory subunit (POLE2) is involved in DNA replication, repair, and cell cycle control, whose association with ESCC is still not clear. Methods: In this study, the expression level of POLE2 in ESCC tissues was detected by IHC. The POLE2 knockdown cell line was constructed, identifed by qPCR and western blot and used for detecting cellular functions and con- structing xenotransplantation mice model. MTT Assay, colony formation assay, fow cytometry, wound-healing assay and Transwell assay were used to detected cell proliferation, apoptosis and migration. Results: We frstly identifed that the expression of POLE2 was overexpressed in ESCC. Moreover, the high expres- sion of POLE2 can predict the tumor deterioration and poor prognosis of ESCC patients. Additionally, downregulation of POLE2 was involved in ESCC progression by promoting proliferation, migration, and inhibiting apoptosis in vitro. In vivo studies proved that POLE2 was positively correlated with ESCC tumor formation, which was consistent with the results in vitro. We also illuminated that POLE2 knockdown upregulated pro-apoptotic proteins (Bax, Caspase3, CD40L, FasL, IGFBP-5 and P21) and downregulated anti-apoptotic proteins (CLAP-2, IGF-I and sTNF-R2).
    [Show full text]
  • Clipped Histone H3 Is Integrated Into Nucleosomes of DNA Replication
    Clipped histone H3 is integrated into nucleosomes of DNA replication genes in the human malaria parasite Plasmodium falciparum Abril Marcela Herrera-solorio, Shruthi Sridhar Vembar, Cameron Ross Macpherson, Daniela Lozano-amado, Gabriela Romero Meza, Beatriz Xoconostle-cazares, Rafael Miyazawa Martins, Patty Chen, Miguel Vargas, Artur Scherf, et al. To cite this version: Abril Marcela Herrera-solorio, Shruthi Sridhar Vembar, Cameron Ross Macpherson, Daniela Lozano- amado, Gabriela Romero Meza, et al.. Clipped histone H3 is integrated into nucleosomes of DNA replication genes in the human malaria parasite Plasmodium falciparum. EMBO Reports, EMBO Press, 2019, 20 (4), pp.e46331. 10.15252/embr.201846331. hal-02321832 HAL Id: hal-02321832 https://hal.archives-ouvertes.fr/hal-02321832 Submitted on 9 Sep 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License Scientific Report Clipped histone H3 is integrated into nucleosomes of DNA replication genes in the human malaria parasite
    [Show full text]
  • Polymerase Δ Deficiency Causes Syndromic Immunodeficiency with Replicative Stress
    Polymerase δ deficiency causes syndromic immunodeficiency with replicative stress Cecilia Domínguez Conde, … , Mirjam van der Burg, Kaan Boztug J Clin Invest. 2019. https://doi.org/10.1172/JCI128903. Research Article Genetics Immunology Graphical abstract Find the latest version: https://jci.me/128903/pdf The Journal of Clinical Investigation RESEARCH ARTICLE Polymerase δ deficiency causes syndromic immunodeficiency with replicative stress Cecilia Domínguez Conde,1,2 Özlem Yüce Petronczki,1,2,3 Safa Baris,4,5 Katharina L. Willmann,1,2 Enrico Girardi,2 Elisabeth Salzer,1,2,3,6 Stefan Weitzer,7 Rico Chandra Ardy,1,2,3 Ana Krolo,1,2,3 Hanna Ijspeert,8 Ayca Kiykim,4,5 Elif Karakoc-Aydiner,4,5 Elisabeth Förster-Waldl,9 Leo Kager,6 Winfried F. Pickl,10 Giulio Superti-Furga,2,11 Javier Martínez,7 Joanna I. Loizou,2 Ahmet Ozen,4,5 Mirjam van der Burg,8 and Kaan Boztug1,2,3,6 1Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, 2CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, and 3St. Anna Children’s Cancer Research Institute (CCRI), Vienna, Austria. 4Pediatric Allergy and Immunology, Marmara University, Faculty of Medicine, Istanbul, Turkey. 5Jeffrey Modell Diagnostic Center for Primary Immunodeficiency Diseases, Marmara University, Istanbul, Turkey. 6St. Anna Children’s Hospital, Department of Pediatrics and Adolescent Medicine, Vienna, Austria. 7Center for Medical Biochemistry, Medical University of Vienna, Vienna, Austria. 8Department of Pediatrics, Laboratory for Immunology, Leiden University Medical Centre, Leiden, Netherlands. 9Department of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, 10Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, and 11Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
    [Show full text]
  • Anti-RPA1 Monoclonal Antibody, Clone 3I21 (DCABH-3680) This Product Is for Research Use Only and Is Not Intended for Diagnostic Use
    Anti-RPA1 Monoclonal antibody, clone 3I21 (DCABH-3680) This product is for research use only and is not intended for diagnostic use. PRODUCT INFORMATION Product Overview Mouse monoclonal to RPA70 Antigen Description Plays an essential role in several cellular processes in DNA metabolism including replication, recombination and DNA repair. Binds and subsequently stabilizes single-stranded DNA intermediates and thus prevents complementary DNA from reannealing.Functions as component of the alternative replication protein A complex (aRPA). aRPA binds single-stranded DNA and probably plays a role in DNA repair; it does not support chromosomal DNA replication and cell cycle progression through S-phase. In vitro, aRPA cannot promote efficient priming by DNA polymerase alpha but supports DNA polymerase delta synthesis in the presence of PCNA and replication factor C (RFC), the dual incision/excision reaction of nucleotide excision repair and RAD51-dependent strand exchange. Immunogen Purified Human RPA70 protein Isotype IgG1 Source/Host Mouse Species Reactivity Human Clone 3I21 Purity Protein G purified Conjugate Unconjugated Applications WB, IP Positive Control HeLa cells Format Liquid Size 500 μl Buffer pH: 7.40; Preservative: 0.09% Sodium azide; Constituents: 99% PBS, 0.02% BSA Preservative 0.09% Sodium Azide Storage Store at +4°C short term (1-2 weeks). Store at -20°C or -80°C. Avoid freeze / thaw cycle. 45-1 Ramsey Road, Shirley, NY 11967, USA Email: [email protected] Tel: 1-631-624-4882 Fax: 1-631-938-8221 1 © Creative Diagnostics
    [Show full text]
  • Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells
    Author Manuscript Published OnlineFirst on October 14, 2019; DOI: 10.1158/1541-7786.MCR-19-0654 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Functional loss of ATRX and TERC activates Alternative Lengthening of Telomeres (ALT) in LAPC4 prostate cancer cells Mindy K. Graham1, Jiyoung Kim1, Joseph Da1, Jacqueline A. Brosnan-Cashman1, Anthony Rizzo1, Javier A. Baena Del Valle1, Lionel Chia1, Michael Rubenstein4, Christine Davis1, Qizhi Zheng1, Leslie Cope2, Michael Considine2, Michael C. Haffner1, Angelo M. De Marzo1,2,3, Alan K. Meeker1,2,3, and Christopher M. Heaphy1,2* 1 Department of Pathology, 2 Department of Oncology, 3 Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA 4 Department of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD 21205, USA Running Title: Effects of ATRX and hTR loss in prostate cancer *To whom correspondence should be addressed: Christopher M. Heaphy: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21231; [email protected] Tel. (443) 287-4730; Fax. (410) 592-5158. Keywords: ATRX, TERC, Telomeres, Alternative lengthening of telomeres, Cancer, Prostate cancer, telomerase, gene knockout, CRISPR/Cas Conflicts of Interest: None 1 Downloaded from mcr.aacrjournals.org on September 30, 2021. © 2019 American Association for Cancer Research. Author Manuscript Published OnlineFirst on October 14, 2019; DOI: 10.1158/1541-7786.MCR-19-0654 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Effects of ATRX and hTR loss in prostate cancer ABSTRACT A key hallmark of cancer, unlimited replication, requires cancer cells to evade both replicative senescence and potentially lethal chromosomal instability induced by telomere dysfunction.
    [Show full text]
  • Family a and B DNA Polymerases in Cancer: Opportunities for Therapeutic Interventions
    biology Review Family A and B DNA Polymerases in Cancer: Opportunities for Therapeutic Interventions Vinit Shanbhag 1,2, Shrikesh Sachdev 2,3, Jacqueline A. Flores 2,3, Mukund J. Modak 4 and Kamalendra Singh 2,3,4,5,* 1 Department of Biochemistry, University of Missouri, Columbia, MO 65211, USA; [email protected] 2 The Christopher S. Bond Life Science Center, University of Missouri, Columbia, MO 65211, USA; [email protected] (S.S.); [email protected] (J.A.F.) 3 Molecular Microbiology and Immunology, University of Missouri, Columbia, MO 65211, USA 4 Department of Microbiology, Biochemistry and Molecular Genetics 225 Warren Street, NJ 07103, USA; [email protected] 5 Department of Laboratory Medicine, Karolinska Institutet, Stockholm 141 86, Sweden * Correspondence: [email protected]; Tel.: +1-573-882-9024 Received: 13 November 2017; Accepted: 29 December 2017; Published: 2 January 2018 Abstract: DNA polymerases are essential for genome replication, DNA repair and translesion DNA synthesis (TLS). Broadly, these enzymes belong to two groups: replicative and non-replicative DNA polymerases. A considerable body of data suggests that both groups of DNA polymerases are associated with cancer. Many mutations in cancer cells are either the result of error-prone DNA synthesis by non-replicative polymerases, or the inability of replicative DNA polymerases to proofread mismatched nucleotides due to mutations in 30-50 exonuclease activity. Moreover, non-replicative, TLS-capable DNA polymerases can negatively impact cancer treatment by synthesizing DNA past lesions generated from treatments such as cisplatin, oxaliplatin, etoposide, bleomycin, and radiotherapy. Hence, the inhibition of DNA polymerases in tumor cells has the potential to enhance treatment outcomes.
    [Show full text]
  • Microrna Modulate Alveolar Epithelial Response to Cyclic Stretch
    University of Pennsylvania ScholarlyCommons Departmental Papers (BE) Department of Bioengineering 2012 MicroRNA Modulate Alveolar Epithelial Response to Cyclic Stretch Nadir Yehya University of Pennsylvania, [email protected] Adi Yerrapureddy University of Pennsylvania John Tobias University of Pennsylvania, [email protected] Susan S. Margulies University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/be_papers Part of the Biomedical Engineering and Bioengineering Commons Recommended Citation Yehya, N., Yerrapureddy, A., Tobias, J., & Margulies, S. S. (2012). MicroRNA Modulate Alveolar Epithelial Response to Cyclic Stretch. BMC Genomics, 13 (154), http://dx.doi.org/10.1186/1471-2164-13-154 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/be_papers/205 For more information, please contact [email protected]. MicroRNA Modulate Alveolar Epithelial Response to Cyclic Stretch Abstract Background MicroRNAs (miRNAs) are post-transcriptional regulators of gene expression implicated in multiple cellular processes. Cyclic stretch of alveoli is characteristic of mechanical ventilation, and is postulated to be partly responsible for the lung injury and inflammation in entilatv or-induced lung injury. We propose that miRNAs may regulate some of the stretch response, and therefore hypothesized that miRNAs would be differentially expressed between cyclically stretched and unstretched rat alveolar epithelial cells (RAECs). Results RAECs were isolated and cultured to express type I epithelial characteristics. They were then equibiaxially stretched to 25% change in surface area at 15 cycles/minute for 1 hour or 6 hours, or served as unstretched controls, and miRNAs were extracted. Expression profiling of the miRNAs with at least 1.5-fold change over controls revealed 42 miRNAs were regulated (34 up and 8 down) with stretch.
    [Show full text]
  • Upregulation of Pole2 Promotes Clear Cell Renal Cell Carcinoma Progression Via AKT/Mtor Pathway and Predicts a Poor Prognosis
    Upregulation of Pole2 Promotes Clear Cell Renal Cell Carcinoma Progression via AKT/mTOR Pathway and Predicts a Poor Prognosis Yajuan Su Tumor Hospital of Harbin Medical University Changfu Li Tumor Hospital of Harbin Medical University Kun Liu Tumor Hospital of Harbin Medical University Liangjun Wei Tumor Hospital of Harbin Medical University Dechao Li Tumor Hospital of Harbin Medical University Wentao Wang Tumor Hospital of Harbin Medical University Yongpeng Xu Tumor Hospital of Harbin Medical University Hongxin Pan Tumor Hospital of Harbin Medical University Lichen Teng ( [email protected] ) Tumor Hospital of Harbin Medical University https://orcid.org/0000-0002-5840-0723 Primary research Keywords: renal cell carcinoma, pole2, survival, cell cycle, apoptosis Posted Date: June 22nd, 2020 DOI: https://doi.org/10.21203/rs.3.rs-35733/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/18 Abstract Background: Pole2 gene is a subunit of DNA polymerases localized in the nucleus, which commonly present in DNA repair. The effect of pole2 in renal cell carcinoma (RCC) still remain unclear. Here we investigate its clinical signicance, function in RCC cells and possible mechanism of effect. Methods: Using TCGA database, we identied that up-regulation of pole2 is associated with poor prognosis in ccRCC. We analyzed association between pole2 expression and T stage or Fuhrman grade. Thus, we investigate the effects of pole2 down-regulation on proliferation, cell cycles, apoptosis and possible mechanism in cells using lentivirus vector with shPole2. Results: Our study showed overexpression of pole2 in ccRCC samples, compared with normal kidney tissues, moreover, high expression of it related to high Fuhrman grade, also may predict poor prognosis in patients with ccRCC (p < 0.05).
    [Show full text]
  • CHK1 Inhibition Is Synthetically Lethal with Loss of B-Family DNA Polymerase Function in Human Lung and Colorectal Cancer Cells
    Author Manuscript Published OnlineFirst on March 11, 2020; DOI: 10.1158/0008-5472.CAN-19-1372 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 1 Title: CHK1 inhibition is synthetically lethal with loss of B-family DNA polymerase function in human lung and colorectal cancer cells. Author List: Rebecca F. Rogers1, Mike I. Walton1, Daniel L. Cherry2, Ian Collins1, Paul A. Clarke1, Michelle D. Garrett2* and Paul Workman1* Affiliations: 1Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SM2 5NG, UK 2 School of Biosciences, Stacey Building, University of Kent, Canterbury, Kent, CT2 7NJ, UK Running title: Synthetic lethality of CHK1 and DNA polymerase inhibition *Corresponding authors: Michelle D Garrett and Paul Workman Corresponding Author Information Michelle D Garrett School of Biosciences, Stacey Building, University of Kent, Canterbury, Kent, CT2 7NJ, UK. Email: [email protected] Phone: +44 (0)1227 816140 Paul Workman Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, SM2 5NG, UK. Email: [email protected] Phone: +44 (0)20 7153 5209 Conflict of interest statement: IC, MDG, MIW, RFR, PC and PW are current or past employees of The Institute of Cancer Research, which has a commercial interest in the discovery and development of CHK1 inhibitors, including SRA737, and operates a rewards-to- inventors scheme. IC, MDG and MIW have been involved in a commercial collaboration on CHK1 inhibitors with Sareum Ltd and intellectual property arising from the program, including SRA737, was licensed to Sierra Oncology. IC is a consultant for Sierra Oncology, Adorx Ltd, Epidarex LLP and Enterprise Therapeutics Ltd and holds equity in Monte Rosa Therapeutics AG.
    [Show full text]
  • Mutations/Polymorphisms in the 55 Kda Subunit of DNA Polymerase Ε in Human Colorectal Cancer
    CANCER GENOMICS & PROTEOMICS 6: 297-304 (2009) Mutations/Polymorphisms in the 55 kDa Subunit of DNA Polymerase ε in Human Colorectal Cancer QI ZHOU1, KATI TALVINEN1, JARI SUNDSTRÖM1, ADEM ELZAGHEID1,*, HELMUT POSPIECH2, JUHANI E. SYVÄOJA2,3 and YRJÖ COLLAN1 1Department of Pathology, University of Turku, FIN-20520 Turku; 2Biocenter Oulu and Department of Biochemistry, University of Oulu, FIN-90014 Oulu; 3Department of Biology, University of Joensuu, FIN-80101 Joensuu, Finland; Abstract. Background: Defects of some DNA polymerases associated features, such as Ki-67 score (3). Proliferation, on have shown associations with cancer, but data on DNA the other hand, is intimately linked with DNA polymerases. polymerase ε are limited. This study investigated mutations This is why we wished to compare the genomic status of the in the 55 kDa subunit gene of DNA polymerase ε in second largest (55 kDa) subunit of DNA polymerase ε colorectal cancer. Materials and Methods: DNA from 16 (POLE2) with several prognostic features to get an idea how human colorectal cancer and 9 control samples was studied genomic abnormalities in DNA polymerase ε might be with polymerase chain reaction–single-strand comformation related to clinical presentation or prognosis associated polymorphism analysis and DNA sequencing. Results: DNA features (4-6). polymerase ε gene alterations were identified in 5 out of the DNA polymerases have a central role in the maintenance 16 cases (31.2%). Two samples showed a T-C transition at of genome integrity, as they are the enzymes that actually exon 17 (potential tyrosine to histidine substitution), and an synthesise DNA (7). At least 14 such polymerases have been A-G transition at intron 7; one sample showed an A-G identified in the mammalian cell, but only three of these, α, transition at intron 8.
    [Show full text]
  • DNA Polymerases at the Eukaryotic Replication Fork Thirty Years After: Connection to Cancer
    cancers Review DNA Polymerases at the Eukaryotic Replication Fork Thirty Years after: Connection to Cancer Youri I. Pavlov 1,2,* , Anna S. Zhuk 3 and Elena I. Stepchenkova 2,4 1 Eppley Institute for Research in Cancer and Allied Diseases and Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA 2 Department of Genetics and Biotechnology, Saint-Petersburg State University, 199034 Saint Petersburg, Russia; [email protected] 3 International Laboratory of Computer Technologies, ITMO University, 197101 Saint Petersburg, Russia; [email protected] 4 Laboratory of Mutagenesis and Genetic Toxicology, Vavilov Institute of General Genetics, Saint-Petersburg Branch, Russian Academy of Sciences, 199034 Saint Petersburg, Russia * Correspondence: [email protected] Received: 30 September 2020; Accepted: 13 November 2020; Published: 24 November 2020 Simple Summary: The etiology of cancer is linked to the occurrence of mutations during the reduplication of genetic material. Mutations leading to low replication fidelity are the culprits of many hereditary and sporadic cancers. The archetype of the current model of replication fork was proposed 30 years ago. In the sequel to our 2010 review with the words “years after” in the title inspired by A. Dumas’s novels, we go over new developments in the DNA replication field and analyze how they help elucidate the effects of the genetic variants of DNA polymerases on cancer. Abstract: Recent studies on tumor genomes revealed that mutations in genes of replicative DNA polymerases cause a predisposition for cancer by increasing genome instability. The past 10 years have uncovered exciting details about the structure and function of replicative DNA polymerases and the replication fork organization.
    [Show full text]
  • Expression of an Ortholog of Replication Protein A1 (RPA1)
    Proc. Natl. Acad. Sci. USA Vol. 94, pp. 9979–9983, September 1997 Plant Biology Expression of an ortholog of replication protein A1 (RPA1) is induced by gibberellin in deepwater rice (cell divisionyintercalary meristemyinternodal growthyOryza sativa) ESTHER VAN DER KNAAP*, SANDRINE JAGOUEIX*†, AND HANS KENDE‡ Michigan State University–Department of Energy Plant Research Laboratory, Michigan State University, East Lansing, MI 48824-1312 Contributed by Hans Kende, July 16, 1997 ABSTRACT Internodes of deepwater rice are induced to antagonist of GA action in rice (6). Growth of the internode grow rapidly when plants become submerged. This adaptation is, ultimately, promoted by GA (5). enables deepwater rice to keep part of its foliage above the The primary target tissue of GA is the intercalary meristem rising flood waters during the monsoon season and to avoid of the internode, where GA enhances cell division activity and drowning. This growth response is, ultimately, elicited by the cell elongation (5, 7, 8). The intercalary meristem is a zone of plant hormone gibberellin (GA). The primary target tissue for about 3 mm in length and is located at the base of the internode GA action is the intercalary meristem of the internode. Using (9). Cells are displaced from the intercalary meristem into the differential display of mRNA, we have isolated a number of elongation zone, where they reach their final size. In GA- genes whose expression in the intercalary meristem is regu- treated internodes, the final cell length is about three to four lated by GA. The product of one of these genes was identified times longer than in control internodes (5, 7).
    [Show full text]